Blucora, Inc. (AVTA) Tops Q4 EPS by 1c

Blucora, Inc. (NASDAQ: AVTA) reported Q4 EPS of ($0.03), $0.01 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $1.88 million versus the consensus estimate of $175.47 million.

For earnings history and earnings-related data on Blucora, Inc. (AVTA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c